Prime Medicine, Inc. (PRME)
3.245
+0.04
(+1.09%)
USD |
NASDAQ |
May 11, 16:00
3.25
0.00 (0.00%)
After-Hours: 19:05
Prime Medicine Shareholders Equity (Quarterly) : 76.70M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | 280.76M |
| Lineage Cell Therapeutics, Inc. | 44.55M |
| RenovoRx, Inc. | 5.422M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Agenus, Inc. | -271.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 294.73M |
| Total Liabilities (Quarterly) | 218.03M |
| Debt to Equity Ratio | 1.493 |
| Current Ratio | 3.800 |
| Net Debt Paydown Yield | -2.35% |